Cargando…
Changing Prescription Drug Sector: New Expenditure Methodologies
Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193600/ https://www.ncbi.nlm.nih.gov/pubmed/10158730 |
_version_ | 1782339004610379776 |
---|---|
author | Genuardi, James S. Stiller, Jean M. Trapnell, Gordon R. |
author_facet | Genuardi, James S. Stiller, Jean M. Trapnell, Gordon R. |
author_sort | Genuardi, James S. |
collection | PubMed |
description | Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outlets emerged and existing sites lost market share. New mechanisms for reimbursing drug purchases led to the flow of rebates between manufacturers and insurers, bypassing retailers. These and other major industry changes required the development of new estimating methodologies for tracking prescription drug expenditures within the National Health Accounts (NHA). |
format | Online Article Text |
id | pubmed-4193600 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
record_format | MEDLINE/PubMed |
spelling | pubmed-41936002014-11-04 Changing Prescription Drug Sector: New Expenditure Methodologies Genuardi, James S. Stiller, Jean M. Trapnell, Gordon R. Health Care Financ Rev Managed Care: Advances in Financing Estimating spending for prescription drugs has become increasingly difficult over the past 15 years as extensive changes have taken place within the retail prescription drug industry. Expenditures for prescription drugs in retail outlets grew rapidly during the 1980s and early 1990s. New retail outlets emerged and existing sites lost market share. New mechanisms for reimbursing drug purchases led to the flow of rebates between manufacturers and insurers, bypassing retailers. These and other major industry changes required the development of new estimating methodologies for tracking prescription drug expenditures within the National Health Accounts (NHA). CENTERS for MEDICARE & MEDICAID SERVICES 1996 /pmc/articles/PMC4193600/ /pubmed/10158730 Text en |
spellingShingle | Managed Care: Advances in Financing Genuardi, James S. Stiller, Jean M. Trapnell, Gordon R. Changing Prescription Drug Sector: New Expenditure Methodologies |
title | Changing Prescription Drug Sector: New Expenditure Methodologies |
title_full | Changing Prescription Drug Sector: New Expenditure Methodologies |
title_fullStr | Changing Prescription Drug Sector: New Expenditure Methodologies |
title_full_unstemmed | Changing Prescription Drug Sector: New Expenditure Methodologies |
title_short | Changing Prescription Drug Sector: New Expenditure Methodologies |
title_sort | changing prescription drug sector: new expenditure methodologies |
topic | Managed Care: Advances in Financing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193600/ https://www.ncbi.nlm.nih.gov/pubmed/10158730 |
work_keys_str_mv | AT genuardijamess changingprescriptiondrugsectornewexpendituremethodologies AT stillerjeanm changingprescriptiondrugsectornewexpendituremethodologies AT trapnellgordonr changingprescriptiondrugsectornewexpendituremethodologies |